Literature DB >> 17297291

Recruitment of Dbl by ezrin and dystroglycan drives membrane proximal Cdc42 activation and filopodia formation.

Clare L Batchelor1, Jen R Higginson, Yun-Ju Chen, Cristina Vanni, Alessandra Eva, Steve J Winder.   

Abstract

Dystroglycan is an essential laminin binding cell adhesion molecule, which is also an adaptor for several SH2 domain-containing signaling molecules and as a scaffold for the ERK-MAP kinase cascade. Loss of dystroglycan function is implicated in muscular dystrophies and the aetiology of epithelial cancers. We have previously demonstrated a role for dystroglycan and ezrin in the formation of filopodia structures. Here we demonstrate the existence of a dystroglycan:ezrin:Dbl complex that is targeted to the membrane by dystroglycan where it drives local Cdc42 activation and the formation of filopodia. Deletion of an ezrin binding site in dystroglycan prevented the association with ezrin and Dbl and the formation of filopodia. Furthermore, expression of the dystroglycan cytoplasmic domain alone had a dominant-negative effect on filopodia formation and Cdc42 activation by sequestering ezrin and Dbl away from the membrane. Depletion of dystroglycan inhibited Cdc42-induced filopodia formation. For the first time we also demonstrate co-localization of Cdc42 and dystroglycan at the tips of dynamic filopodia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17297291     DOI: 10.4161/cc.6.3.3819

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  19 in total

1.  The tumor suppressor hamartin enhances Dbl protein transforming activity through interaction with ezrin.

Authors:  Marzia Ognibene; Cristina Vanni; Daniela Segalerba; Patrizia Mancini; Elisa Merello; Maria Rosaria Torrisi; Maria Carla Bosco; Luigi Varesio; Alessandra Eva
Journal:  J Biol Chem       Date:  2011-06-28       Impact factor: 5.157

2.  Interactome analysis reveals ezrin can adopt multiple conformational states.

Authors:  Raghuvir Viswanatha; Jessica Wayt; Patrice Y Ohouo; Marcus B Smolka; Anthony Bretscher
Journal:  J Biol Chem       Date:  2013-10-22       Impact factor: 5.157

Review 3.  Biological role of dystroglycan in Schwann cell function and its implications in peripheral nervous system diseases.

Authors:  Toshihiro Masaki; Kiichiro Matsumura
Journal:  J Biomed Biotechnol       Date:  2010-06-15

4.  Dystroglycan versatility in cell adhesion: a tale of multiple motifs.

Authors:  Chris J Moore; Steve J Winder
Journal:  Cell Commun Signal       Date:  2010-02-17       Impact factor: 5.712

5.  Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer.

Authors:  G Mathew; A Mitchell; J M Down; L A Jacobs; F C Hamdy; C Eaton; D J Rosario; S S Cross; S J Winder
Journal:  Sci Rep       Date:  2013-09-30       Impact factor: 4.379

6.  Depletion of the actin bundling protein SM22/transgelin increases actin dynamics and enhances the tumourigenic phenotypes of cells.

Authors:  Oliver Thompson; Jeelan S Moghraby; Kathryn R Ayscough; Steve J Winder
Journal:  BMC Cell Biol       Date:  2012-01-18       Impact factor: 4.241

7.  Modulation of cell spreading and cell-substrate adhesion dynamics by dystroglycan.

Authors:  Oliver Thompson; Chris J Moore; Sadaf-Ahmahni Hussain; Iivari Kleino; Michelle Peckham; Erhard Hohenester; Kathryn R Ayscough; Kalle Saksela; Steve J Winder
Journal:  J Cell Sci       Date:  2010-01-01       Impact factor: 5.285

8.  Polarization and myelination in myelinating glia.

Authors:  Toshihiro Masaki
Journal:  ISRN Neurol       Date:  2012-12-30

9.  Positive feedback between Cdc42 activity and H+ efflux by the Na-H exchanger NHE1 for polarity of migrating cells.

Authors:  Christian Frantz; Anastasios Karydis; Perihan Nalbant; Klaus M Hahn; Diane L Barber
Journal:  J Cell Biol       Date:  2007-11-05       Impact factor: 10.539

10.  Muscle dystroglycan organizes the postsynapse and regulates presynaptic neurotransmitter release at the Drosophila neuromuscular junction.

Authors:  Laurent Bogdanik; Bérénice Framery; Andreas Frölich; Bénédicte Franco; Dominique Mornet; Joël Bockaert; Stephan J Sigrist; Yves Grau; Marie-Laure Parmentier
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.